Literature DB >> 7007710

Kidney transplant nephrotic syndrome: relationship between allograft histopathology and natural course.

J S Cheigh, J Mouradian, M Susin, W T Stubenbord, L Tapia, R R Riggio, K H Stenzel, A L Rubin.   

Abstract

We analyzed clinical and pathologic data from 36 recipients of 38 renal allografts who developed nephrotic syndrome following transplantation. Three groups were identified on the basis of histologic changes in the graft, and each group had a distinct clinical course. Nine grafts (23.7%) had recurrent glomerulonephritis (GN) (5 membrano-proliferative, 4 focal glomerulosclerosis) and developed nephrotic syndrome at 5.1 months (mean) posttransplant. Renal function deteriorated rapidly, with a 2-year graft survival of 29.7%. Four grafts (10.5%) with de novo GN (3 epimembranous, 1 minimal change) developed nephrotic syndrome at 32 months posttransplant, and all functioned for more than 3 years. Twenty-five grafts (65.8%) had allograft glomerulopathy with the onset of nephrotic syndrome at 9.1 months posttransplant and a 2-year graft survival of 66.6%. The differences in duratin of graft function between grafts with allograft glomerulopathy and recurrent GN (P < 0.01) and in graft survival rates at 2 years among the three groups (P < 0.05) are statistically significant. This analysis indicates that allograft glomerulopathy is the most common cause of kidney transplant nephrotic syndrome. Membranoproliferative GN and focal glomerulosclerosis may recur soon after transplantation and rapidly progress to renal failure in marked contrast to grafts with either de novo epimembranous nephropathy or minimal glomerular change, lesions that are compatible with prolonged graft function.

Entities:  

Mesh:

Year:  1980        PMID: 7007710     DOI: 10.1038/ki.1980.146

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Clinicopathological quiz. De novo membranous glomerulonephritis (MGN).

Authors:  C Antignac; M Broyer; N Hinglais; R Habib
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

2.  De novo membrano-proliferative glomerulonephritis in a renal allograft.

Authors:  W Pommer; G Schultze; D Bohl; P H Krause
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

3.  Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.

Authors:  Thomas M Kitzler; Nadezda Kachurina; Martin M Bitzan; Elena Torban; Paul R Goodyer
Journal:  Pediatr Nephrol       Date:  2018-07-07       Impact factor: 3.714

4.  Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.

Authors:  Jei-Wen Chang; Victoriano Pardo; Junichiro Sageshima; Linda Chen; Hsin-Lin Tsai; Jochen Reiser; Changli Wei; Gaetano Ciancio; George W Burke; Alessia Fornoni
Journal:  Transplantation       Date:  2012-06-27       Impact factor: 4.939

Review 5.  Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis.

Authors:  M R First
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

6.  A de novo monoclonal immunoglobulin deposition disease in a kidney transplant recipient: a case report.

Authors:  Benjamin Savenkoff; Perrine Aubertin; Marc Ladriere; Cyril Hulin; Jacqueline Champigneulle; Luc Frimat
Journal:  J Med Case Rep       Date:  2014-06-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.